brimonidine

(redirected from Brimonidine tartrate)

brimonidine

 [brĭ-mo´nĭ-dēn]
an alpha-adrenergic receptor agonist used as the tartrate salt in treatment of open-angle glaucoma and ocular hypertension; administered topically to the conjunctiva.

brimonidine

A drug used in the form of eyedrops in the treatment of GLAUCOMA. The drug may be used when beta-blocker eyedrops are medically undesirable or when they are inadeqately effective in controlling the glaucoma. A brand name is Alphagan.
References in periodicals archive ?
Among the new products, Bausch + Lomb's Lumify redness reliever eye drops are providing innovation and growth to the eye care category as the first and only O-T-C drops containing low-dose brimonidine tartrate. Backed by six clinical studies, Lumify has a strong efficacy and safety profile with low risk for rebound redness and 95% symptom improvement seen at one minute and lasting up to eight hours.
Bausch + Lomb announced the launch of LUMIFY, the first and only over-the-counter eye drop developed with low-dose brimonidine tartrate for the treatment of eye redness.
For persistent erythema, topical alpha-adrenergic receptor agonists including brimonidine tartrate and oxymetazoline have been shown to reduce erythema by vasoconstricting blood vessels, although some products are associated with a rebound erythema on treatment discontinuation.
IOP of the OD remained consistently above 50 mmHg with medications provided (i.e., travoprost, timolol, brinzolamide, brimonidine tartrate, and mannitol 20%).
Can be pro-inflammatory in CMO, reactivate herpes simplex Apraclonidine lopidine Sympathomimetics 0.5% 5mL BC alpha2 Aqonists 1.0% unlicensed for Preservative free Stinging/burning, glaucoma allergy, blurring Brimonidine tartrate Brimonidine Tartrate Conjunctival 0.2% 5mL BC erythema, dry mouth, 0.2% 5mL Alphagan headache, drowsiness, Neuro-protective BC fatigue, dizziness, in NTG gastro intestinal symptoms Acetazolamide Diamox Carbonic anhydrase 250mg tablet inhibitors 500mg powder for Diamox SR Electrolyte injection 250mg Sustained release disturbances.
M2 PHARMA-August 10, 2017-FDA Grants Ocugen Orphan Drug Designation for OCU300 (brimonidine tartrate) for Treatment of Ocular Graft Versus Host Disease
These drugs with neuroprotective properties are being investigated as treatments for dry AMD: an implanted encapsulated cell technology (NT-501, Neurotech); intravitreal brimonidine tartrate (Allergan); and topical tandospirone (AL-8309B; Alcon) [Table 2].
Hasanreisoglu, "Neuroprotective effect of topically applied brimonidine tartrate 0.2% in endothelin-1-induced optic nerve ischaemia model," Clinical and Experimental Ophthalmology, vol.
A 1-year, open-label safety trial evaluated approximately 345 subject-years of exposure to brimonidine tartrate gel 0.5%.
Brimonidine tartrate is a potent third generation alpha-2 adrenergic agonist and has more than 1000-fold selectivity for alpha-2 over alpha-1 receptors.
The two coming attractions are brimonidine tartrate 0.5% gel and oxymetazoline cream.